🇺🇸 FDA
Pipeline program

PBSCs

NFEC-2021-126

Phase 3 other completed

Quick answer

PBSCs for Hematological Malignancies is a Phase 3 program (other) at Hospital Authority, Hong Kong with 1 ClinicalTrials.gov record(s).

Program details

Company
Hospital Authority, Hong Kong
Indication
Hematological Malignancies
Phase
Phase 3
Modality
other
Status
completed

Clinical trials